XEBIO Holdings CO., LTD.

As of March 31, 2026, XEBIO Holdings CO., LTD. carries a market capitalization of 41.05B, placing it among publicly traded companies globally. Its enterprise value stands at 31.68B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

XEBIO Holdings CO., LTD.'s next confirmed earnings release is scheduled for November 13, 2026.

As of March 31, 2026, XEBIO Holdings CO., LTD. has 41.38M shares outstanding.

These figures are as of March 31, 2026.

As of March 31, 2026, XEBIO Holdings CO., LTD. maintains a current ratio of 1.83, meaning it holds 1.8x the short-term assets needed to cover near-term liabilities.

These figures cover the twelve months ended March 31, 2026.

As of the close on October 22, 2026, XEBIO Holdings CO., LTD.'s stock has declined approximately 4.92% over the past 52 weeks. The 50-day moving average sits at 1,130.12, while the 200-day moving average is 1,075.61.

As of March 31, 2026, XEBIO Holdings CO., LTD. holds 15.81B in cash and equivalents against 6.29B in total debt, resulting in a net debt position of -12.92B. Total book value stands at 118.16B, with working capital of 60.41B providing operational flexibility.

XEBIO Holdings CO., LTD.'s most recent stock split took place on March 28, 2006 with a 2:3 split ratio.